Histopathology for IBD Diagnosis
Histopathology for IBD Diagnosis
SECTION 3
CHAPTER
Histopathology of Crohn’s
18 Disease and Ulcerative Colitis
K. GEBOES
Goal
Introduction SECTION 3
To review the important histologic features required for the Ulcerative colitis (UC) and Crohn’s disease (CD) are
diagnosis, assessment of disease activity and early chronic inflammatory bowel diseases of unknown cause.
detection of malignancy. The variability of features with Clinically, both conditions usually begin gradually, but
time and treatment and difficult differential diagnostic they can start abruptly and sometimes even present as
problems will be discussed. fulminant disease.The clinical course is characterized by
exacerbations and spontaneous or drug-induced remis-
Key points sions. UC primarily affects the mucosa of the large
• Histopathology can help to solve many diagnostic bowel, while CD is a transmural disease that can affect
problems, especially when multiple biopsies of the colon the whole gastrointestinal tract.The various clinical pat-
and ileum are available. terns are reflected in the microscopic features observed
• Exacerbations and remissions are reflected by mucosal in biopsies obtained from surgical specimens or during
inflammation and activity of variable intensity, including endoscopy. Endoscopic mucosal biopsies will not show
healing. all the characteristic features of CD. Review of biopsies,
• Multiple biopsies are also indicated for the early in combination with clinical, laboratory, radiographic
detection of pre-cancerous lesions and cancer in and endoscopic observations, is used for the diagnosis of
ulcerative colitis and Crohn’s disease. UC and CD and the differentiation from other condi-
tions. Such differentiation is important because a precise
Key references diagnosis is essential for appropriate treatment.1–3 A
• Schumacher G, Kollberg B, Sandstedt B. A prospective correct diagnosis is possible in the large majority of
study of first attacks of inflammatory bowel disease and patients; still, in some patients with acute onset or fulmi-
infectious colitis. Histologic course during the 1st year nant disease, a precise diagnosis may be difficult to reach,
after presentation. Scand J Gastroenterol 1994; resulting in a temporary diagnosis of indeterminate
29:318–332. colitis (IC). Biopsies also allow assessment of disease
• Jenkins D, Balsitis M, Gallivan S et al. Guidelines for the
activity and identification of pre-cancerous lesions and
initial biopsy diagnosis of suspected chronic idiopathic
cancer. In clinical practice, often only rectal biopsies are
inflammatory bowel disease. The British Society of
obtained for diagnosis. However, in contrast with UC,
Gastroenterology Initiative. J Clin Pathol 1997; 50:
the rectum is not always involved in CD and lesions
93–105.
in CD frequently occur in a background of normal
mucosa.Therefore it is more appropriate to take multiple
• Shepherd NA. Pathological mimics of chronic
endoscopic biopsies in different segments of the colon
inflammatory bowel disease. J Clin Pathol 1991;
(and ileum) during the initial work-up of a patient pre-
44:726–733
senting with inflammatory diarrhea or during follow-up
and screening for cancer. Multiple biopsies permit an in-
depth analysis of the distribution of inflammation and 255
are essential for the recognition of dysplasia. It also
IBD4E-18(255-276) 03/04/2003 10:32 AM Page 256
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
ULCERATIVE COLITIS
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
Architecture
Severe crypt architectural distortion
Severe widespread decreased crypt density
Frankly villous surface
Inflammatory
Heavy diffuse transmucosal lamina propria cell increase
Diffuse basal plasmacytosis
Miscellaneous
Increased intensity of the alterations towards the distal colon
Severe mucin depletion
Paneth-cell metaplasia distal to the hepatic flexure
ULCERATIVE COLITIS
Fig. 18.4 Ulcerative colitis. Distortion of the mucosal Fig. 18.6 Ulcerative colitis. Quiescent phase characterized by an
architecture can persist in quiescent ulcerative colitis. The crypts abnormal architecture and diffuse thickening of the muscularis
are widely separated from the underlying muscularis mucosae. mucosae. (H&E × 10)
Some of the crypts are branching. (H&E × 10). SECTION 3
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
Disease activity
Histology as a tool for the measurement of disease
activity of UC was introduced in the 1950s.The altera-
tions in intensity and composition of the lamina propria
infiltrate, which can be observed in routinely processed
sections stained with hematoxylin and eosin, allow a dis-
tinction between active, inactive and quiescent disease.
Active disease is defined by the presence of neutrophils
Fig. 18.7 Ulcerative colitis. Mucosal atrophy with loss of crypts.
in association with epithelial cell damage.13 Inactive
Neutrophils are still present in the lumen and wall of one of the
chronic disease is defined as the presence of architec- crypts indicating persistent activity. (H&E × 10). (With permission
tural changes and an increase of lamina propria mono- from Geboes et al. Gut 2000; 47: 404–409.)
nuclear cells. Quiescent disease means the presence of
structural changes without alterations in intensity and
composition of the lamina propria infiltrate. Over the scores may be used to either document disease evolu-
years, several microscopic scores for the assessment of tion, or to assess clinical efficacy in therapeutic trials.
disease activity in UC have been developed, generally Histological assessment of disease activity could be
for study purposes (Table 18.2).20,21 The reproducibility important for the prediction of relapse. Clinical trials
of activity scores has not been studied extensively, but have indeed shown that persistent active inflammation
the limited data available show good agreement between and basal plasmacytosis are associated with an increased
different observers.22 The microscopic pattern of activity frequency of relapse (Fig. 18.7).23
generally correlates well with endoscopic features of In fulminant disease, mucosal inflammation may
severity, although in endoscopically inactive disease, extend towards the submucosa and focally even towards
260 the muscularis propria (proportionate inflammation).
microscopic features of activity may persist.The activity
IBD4E-18(255-276) 03/04/2003 10:33 AM Page 261
CROHN’S DISEASE
Crohn’s Disease
Fig. 18.8 Ulcerative colitis. Mucosal biopsy obtained 6 weeks
after the start of medical treatment with 5-ASA showing limited Gross features
mucosal distortion and disappearance of activity. (H&E × 10)
CD can affect different segments of the GI tract. The SECTION 3
appearances are similar at all levels. The terminal ileum
Transmural lymphoid hyperplasia is however highly and proximal colon are the most common sites, fol-
unusual. lowed by the anorectum and colon. Perianal disease
A significant association between disease activity and varies between 14–76%. Involvement of the upper
numbers of immunoglobulin-containing cells in the gastrointestinal tract is uncommon. The length of the
lamina propria has been demonstrated.24 Upregulation segments involved is variable and the lesions are sepa-
of adhesion molecules and other markers is also related rated by uninvolved ‘skip areas’. Macroscopic lesions
with disease activity. Several studies have shown are apparent on the mucosal and serosal side of the
increased or aberrant colonic epithelial cell expression bowel wall. In the Vienna classification proposed by an
of HLA-DR, MHC class II molecules and reduction or International Working Party for the World Congress of
disappearance with different types of treatment. The Gastroenterology in 1998, a distinction is made between
expression of activation markers and the assessment of inflammatory disease, stricturing disease – defined as
immunoglobulin-containing cells are however not constant luminal narrowing – and penetrating disease,
useful in routine practice. defined by the occurrence of intra-abdominal or peri-
anal fistulas, inflammatory masses and/or abscesses.
Medical treatment Fistulas are commonly associated with strictures and
Topical and systemic medical treatments have a major therefore the clinical distinction is often limited to
impact upon histology in UC. Mucosal injury and neu- two types: the perforating type and non-perforating
trophils can diminish substantially within 4 weeks, or type with predominantly mucosal lesions. The mucosal
even disappear. Normalization with disappearance of appearance is usually heterogeneous. Lesions of different
architectural alterations of the crypts and surface size are simultaneously present.The mucosa may appear
together with reduction of the cellular lamina propria normal or may show multiple small (1–2 mm in size)
infiltrate takes more time, but can occur (Fig. 18.8).25 punctiform, rounded nodules or superficial erosions
In many cases, the inflammatory features become dis- known as ‘aphthoid lesions’. Over a period of time, the
continuous and heterogeneous. This may make a differ- erosions become confluent and give rise to larger longi-
ential diagnosis between UC and CD difficult. It is tudinal ulcers, known as serpiginous ulcers.28 The com-
therefore important to know treatment and its effects bination of longitudinal and transverse ulceration in an
upon histology when analysing a biopsy.26 edematous mucosa induces a characteristic ‘cobblestone’
aspect. Ulcerations are more common on the mesen-
Pouchitis teric border of the small intestine. They can become
Treatment of ulcerative colitis with total colectomy and deeply situated fissuring ulcers reaching the muscularis
creation of a continent ileoanal anastomosis is not propria or pass through the muscularis and give rise to
uncommonly accompanied by inflammation of the ileal abcesses or fistulas between involved segments and
pouch. Histologically there is normally slight mucosal adjacent organs or nearby uninvolved loops. Fistulas are
inflammation, but occasionally crypt abscesses, ulcera- defined as abnormal communications between the
tion and blunting of the villi are seen. Sequential biop- lumen of the gut and the mesentery and/or another 261
IBD4E-18(255-276) 03/04/2003 10:34 AM Page 262
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
Microscopic features
Fig. 18.10 Crohn’s disease. Small intestine: fat wrapping is a Granuloma
characteristic feature of Crohn’s disease. It is characterized by the Granulomas in histological sections are a key feature of
overgrowth of mesenteric fat. CD.33 It should however be remembered that granulo-
mas can occur in other conditions, especially infectious
diseases, such as tuberculosis and Yersinia pseudo-
hollow organ or the abdominal wall and skin. Histo- tuberculosis and occasionally in drug-induced colitis. A
logically, they are composed of granulation tissue, sur- granuloma is defined as a collection of monocyte/
rounding a lumen, which is mostly filled up by nuclear macrophage cells and other inflammatory cells with or
debris and inflammatory cells, in particular neu- without giant cells (Fig. 18.11).The macrophages appear
trophils.29 Granulomas are present in approximately 25% as large cells with abundant pale eosinophilic cytoplasm
of the perianal fistulas or abscesses. Fistulas are often and large oval nucleus. They are arranged in clusters.
associated with strictures. Strictures are characterized by Because of this epithelial cell-like morphology, they
luminal narrowing and bowel wall thickening with or are called epithelioid cells. The cells can be closely
without prestenotic dilatation. In high-grade stenosis, packed together, and have a sarcoid-like aspect but a
the luminal diameter is less than 0.5 cm.They are often ‘loose’ expanded form of granuloma is more common
associated with severe ulcerations with complete cir- in CD (Fig. 18. 12). Central necrosis and caseation are
cumferential loss of the mucosa (Fig. 18.9). In rare cases, rare findings and should raise suspicion of tuberculosis.
CD can present a macroscopic picture of the left colon Giant cells may contain calcified conchoid bodies.27,34
with continuous involvement, reminiscent of UC, in Associated inflammatory cells are lymphocytes, usually
262
association with ileal disease.30 CD4+ T cells, showing expression of CD28, the ligand
IBD4E-18(255-276) 03/04/2003 10:34 AM Page 263
CROHN’S DISEASE
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
Mucosal lesions
E A R LY M U C O S A L L E S I O N S
Various types of early microscopic lesions have been
described in CD.They occur as focal lesions, in a back-
ground of normal mucosa in contrast with UC where
diffuse epithelial necrosis is seen. Early lesions in CD
include epithelial patchy necrosis, the aphthoid ulcer or
mucosal microulcerations (loss of 1–6 cells). Other fea-
tures include the occurrence of a naked surface of the
dome area overlying a mucosal lymph follicle and loss of
M cells. Ulcers at the base of crypts with neutrophils
streaming into the bowel lumen, which leads in a later
phase to mountain peak ulcers, villous abnormalities
and damage of small capillaries (including capillary Fig. 18.13 Crohn’s disease. Aphthoid ulcer in the ileum: early
thrombi) with subsequent loss of surface epithelial cells mucosal ulcer, centrally located and appearing as a mountain top
(summit lesion) have been reported (Figs 18.13 and ulcer. (H&E × 4)
18.14).35–39 In general, limited necrosis of surface
epithelial cells is common while crypt epithelial cells are
rarely involved (an exception is the ulcer at the crypt of IBD. It has been suggested that the diagnosis of CD
base). Overall, biopsies of early lesions do not yield should be based upon the presence of an epithelioid
essential diagnostic information. An exception to this granuloma with one other feature suggestive or diagnos-
may be the aphthoid ulcer.This ulcer has a predilection tic for IBD, or the presence of three other features in the
for the epithelium overlying the lymphoid follicles, absence of granulomas, provided that specific infection
although it can occur in other sites too. According to has been excluded.40 The mucosal lesions of IBD consist
some studies, biopsies of aphthoid ulcers show more of epithelial alterations and a cellular inflammatory
commonly the characteristic granulomas, which are response.The former include cytological and architectural
diagnostic for CD.34 changes, indicative of damage and repair. The cellular
inflammatory response consists of changes in intensity of
D I AG N O S T I C F E AT U R E S the infiltrate, alterations in composition and changes in
Although the degree of mimicry with UC can be high, the distribution pattern. These features have been exam-
the presence of aphthoid ulcers, fissure ulcers, transmural ined in a number of studies of rectal and colorectal biop-
inflammation, fistulas, lymphangiectasia, fibrous strictur- sies and surgical specimens. Only a limited number have
ing and neural changes is predominantly a feature of CD. acceptable sensitivity, specificity and predictive value
Six of these features proposed cannot, however, be reli- and are sufficiently reproducible (Table 18.3). Features
ably detected on endoscopic samples. A diagnosis of CD that favor CD are epithelioid granulomas, relatively
on endoscopic samples of the colon therefore relies unchanged crypts or segmental distribution of crypt
264 heavily on the identification of the microscopic features atrophy and crypt distortion together with discontinuous
IBD4E-18(255-276) 03/04/2003 10:35 AM Page 265
CROHN’S DISEASE
Mucosal architecture
Mucosal surface, normal, irregular, villous
Crypt atrophy (shortened, widely spaced crypts)
Distorted, dilated, branching crypts
Inflammatory changes
Basal plasmacytosis, increase in cells in basal third of lamina
propria
Increased lamina propria cellularity (round cells and
neutrophils)
Basal lymphoid aggregates
Specific features
Epithelioid granuloma
Basal giant cells
Excess histiocytes in lamina propria SECTION 3
Features related with activity (separating IBD from normal)
Neutrophils in surface epithelium
Neutrophils in crypt epithelium
Ulceration
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
of ileal lesions is however another key lesion, which The value of multiple, multi-step biopsies
allows to discriminate between UC and CD. Important The importance of stepwise biopsies for the diagnosis of
diagnostic microscopic features of CD are architectural either CD or UC has received little attention in the
abnormalities of the villi (irregularity and blunting or literature. Most studies have focused on single rectal
broadening), preserved mucin secretion or increased biopsies. Discontinuous inflammation in stepwise biop-
mucin production (hypercrinia) by epithelial cells, sies does not distinguish CD from UC in adults. It can
mucoid or pseudopyloric metaplasia, active chronic be found in approximately 30% of patients with long-
inflammation and the presence of granulomas.44 Pseudo- standing UC but it discriminates in children and in
pyloric gland metaplasia is however a non-specific feature patients with a short history of the disease.The presence
related with ulceration, healing and the ulcer associated of an inflammatory infiltration with decreasing intensity
cell lineage (Fig. 18.16).45 from caecum to rectum favors a diagnosis of CD.12,46 In
Immunohistochemical analysis of mucosal biopsies combination with ileal biopsies, multiple colonic biop-
reveals expression of various cytokines and other media- sies are useful for the diagnosis.
tors, such as interleukin-10, interleukin-12, interleukin-
15 and tumor necrosis factor alfa (TNFα ). Some markers Disease activity: effect of treatment
may be more specific for CD but increased expression Microscopic assessment of disease activity in CD is
indicates mainly ongoing immune response and has no difficult because of the segmental and transmural char-
diagnostic value at present. acter of the disease. Yet, several scoring systems have
been designed and even used in clinical trials. These
scores are usually based on the microscopic analysis of
multiple biopsies from different segments. The correla-
tion between endoscopic findings, clinical indices of
disease activity and microscopic scores is variable.47 This
reflects the fact that mucosal biopsies are not representa-
tive of the transmural inflammation and that clinical fea-
tures are not always reliable indicators of disease activity
at the tissue level. Mucosal biopsies however do reflect
mucosal inflammation. Monotherapy with corticos-
teroids or 5-ASA has only a limited influence upon
mucosal lesions in CD, although long-term combina-
tion treatment may induce normalization. Reduction of
epithelioid granulomas with persistent chronic inflamma-
tion has been reported following long-term treatment
with prednisolone, sulfasalazine and 6-mercaptopurine.
In contrast, polymeric diet and immunomodulatory
therapy with azathioprine and infliximab can pro-
foundly influence the histologic lesions and induce
healing.48–50
CROHN’S DISEASE
myentericus are not uncommon. A three-fold increase significance are unquestionable. Lymphangiectasia in the
in the number of ganglion cells of the ileal myenteric submucosa is another common finding in CD in addi-
plexus was recorded in a series of 24 cases with CD. All tion to granulomatous vasculitis.55
these features were shown to be highly suggestive for a
diagnosis of CD with a significant difference between LY M P H O I D H Y P E R P L A S I A
UC and CD and they can be detected with great Lymphoid aggregates and nodules with or without ger-
reliability.51 minal centres are common in the mucosa and even
Ultrastructural studies have shown that nerve fibers more numerous in the submucosa in CD. They occur
or axons appear as swollen, empty structures.52 The also in the muscularis propria, in the vicinity of the
specificity of this lesion for CD has however not been myenteric plexus and in the subserosa. This transmural
confirmed. A relative increase in myenteric neurones lymphoid hyperplasia is believed to be characteristic for
containing nitric oxide synthase (NOS), vasoactive CD and is not observed in UC or IC.56
intestinal peptide (VIP) and pituitary adenylate cyclase
activating peptide (PACAP) and an abnormal pattern E D E M A , F I B RO S I S, F I B RO M U S C U L A R
of VIP containing fibers have been recognized in CD.53 O B L I T E R AT I O N S, S T R I C T U R E S
Immunohistochemistry revealed also increased MHC Widening of the submucosa by edema is common in
class II (HLA-DR) membranous expression on enteric CD and probably a sign of active disease. Strictures are
glial cells in macroscopically involved and uninvolved a common complication of CD and an indication for SECTION 3
areas. The enhanced expression is positively correlated surgery in approximately 50% of all CD patients.
with the local intensity of the cellular inflammatory Histological studies of strictures show marked expan-
infiltrate. Induction of HLA-DP and DQ antigens on sion of the muscularis mucosae by an irregular increase
glial cells is restricted to areas of moderate and high in the number of smooth muscle cells in this layer and
inflammatory activity.51 the presence of large amounts of collagen, laminin and
tenascin. Types V and III collagen can be abundantly
VA S C U L A R L E S I O N S present (Fig. 18.18). Mast cells can be numerous. In
Inflammatory cell infiltration of blood vessels and oblit- addition to the expansion of the muscularis mucosae
erative lesions have been observed with microscopy in per se, islands of smooth muscle cells and myofibroblasts
surgical samples from patients with CD in a number of are noted in disorganized fashion in the adjacent sub-
studies. The frequency varies between 3% and 85%. mucosa. Smooth muscle cell fibers may interconnect
The frequency of vascular granulomatous inflamma- the muscularis mucosae and propria. The submucosa
tion varies between 3–100% of the cases examined contains dense masses of large amounts of collagenous
(Fig. 18.17).54 Granulomas are not only found in associ- material and the luminal margin of the muscularis
ation with blood vessels. They may even be more propria is disorganized with numerous collagenous
common in lymphatic channels. While the nature and
the exact frequency of granulomatous vasculitis in CD
remain to be determined, its occurrence and diagnostic
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Ulcerative colitis or Crohn’s disease
Several studies have examined a large variety of mucosal Fig. 18.20 Ulcerative colitis. Relapse of disease symptoms in
biopsy criteria for the distinction between UC and CD ulcerative colitis can be due to infection with cytomegalovirus.
and shown wide overlap.2 The situation is different The virus can be recognized by typical nuclear inclusions.
when surgical specimens are involved, because CD is (H&E × 25)
characterized by transmural inflammation, whereas UC
is a mucosal disease. In most studies examining endo- crypt abscesses have no significant discriminative value
scopic mucosal biopsies, the criteria, which discriminate (Table 18.4).
between UC and CD, have a sensitivity and specificity
exceeding only 75%.The histological diagnosis is largely
based on the finding of granulomas in addition to the
Infectious and drug-related colitis
presence of criteria for the diagnosis of IBD, especially A variety of infectious or drug-related colitides may clin-
mucosal distortion. Segmental distribution of crypts or ically mimic CD or UC, especially those cases with
crypt atrophy, segmental distribution of mucin deple- abrupt clinical onset. Acute inflammatory diarrhea
tion, mucin preservation at the edge of an ulcer or in accompanied by fever and evidence in stool of an
crypts with surrounding neutrophils, the occurrence of inflammatory process such as pus, mucus and blood, and
focal inflammation simultaneously with severe diffuse or dysentery, a more severe manifestation of inflammatory
patchy inflammation in a set of biopsies, have a signifi- diarrhea with, in addition, abdominal pain cramps and
cant discriminative value in favor of CD. Furthermore, rectal tenesmus, are indeed often due to infectious agents.
in contrast to UC, typical CD shows a segmental or These can be divided into two subgroups – organisms
focal distribution of the disease in the bowel and focal that elicit an inflammatory process by penetrating the
or patchy inflammation within a biopsy specimen.These mucosa, and those that elaborate cytotoxins without
features can reliably be assessed with good agreement invading the cells. Worldwide, invasive bacterial agents
between observers. In contrast, Paneth-cell metaplasia constitute the most important subgroup of etiologic
has only limited discriminative value while cryptitis and agents. A precise diagnosis is essential for a proper treat- 269
IBD4E-18(255-276) 03/04/2003 10:36 AM Page 270
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
Table 18.4 Frequency of detection (%) of the reproducible features for different diagnoses
Architecture
Irregular surface 0–5 0–7 39 63 24
Branched crypts 0–5 75 63–83 39–67
Crypt shortening 0–5 0 29–78 12–37
Chronic inflammation
Increased basal cellularity 0 0 63 62
Increased lamina propria cellularity 0–19 30 89–93 76–92 72–81
Granulomas 0 0–2 25–27 0–5 21–100
Discontinuous inflammation 7 10 26
Epithelial alterations
Mucin depletion 17 35–69 5–57
Mucin preservation at ulcer edge – +++
Neuronal changes 2 75
IBD, inflammatory bowel disease; UC, ulcerative colitis; CD, Crohn’s disease.
ment. Histology, in collaboration with other methods of infection with Clostridium difficile. The differential
plays an important role in establishing a correct diagno- diagnosis of CD includes mainly bacterial diseases due to
sis.41 The histology of infectious-type colitis is variable, Yersinia enterocolitica and Campylobacter jejuni, which can
due to the natural course of the disease and to differences both affect the ileum and proximal colon (Fig. 18.21).
in the virulence of the bacterial strain and the reaction of Special attention is required for tuberculosis and amoebi-
the host, but in general it shows a picture of active asis because of the indolent nature of these infections and
inflammation with normal mucosal architecture. A the negative effect of a treatment with corticosteroids or
normal biopsy or mild edema can be seen when bacteria immunosuppressants.Tuberculosis is commonly found in
are non-invasive. Active inflammation may be mild or the terminal ileum and ileocecal region but, in contrast to
severe with extensive necrosis. In mild or moderate CD, it is rare in the large intestine. Unlike the longitudi-
disease, neutrophils are found in the upper part of nal serpiginous ulcers of CD, tuberculous ulcers tend to
the lamina propria. Cryptitis, with neutrophils usually in be circumferential or transverse. Examination of ileal or
the upper, more luminal part, superficial crypt abscesses colonic biopsies can reveal specific features. Granulomas
and erosions are common. The lesions show a focal or
patchy distribution. Neutrophils are more common in the
early phase of the disease. Residual lesions appear later.
An increase of plasma cells is observed 7–10 days after
the initial onset of the disease. Increased numbers of IgA-
and IgM-containing plasma cells are found in the mucosa
in patients with Campylobacter colitis, in contrast with
patients with active UC, who show increases of IgA and
IgG.The crypts remain parallel, but they are often smaller
at the upper part. The distinction between IBD and
infective type colitis relies mainly on the absence of fea-
tures (architectural and basal plasmacytosis) which direct
towards a diagnosis of chronic idiopathic inflammatory
bowel disease. In rare occasions, such as Entamoeba his-
tolytica or CMV infection, the pathogen can be identified.
CMV infection constitutes a special situation. It may be
present in the early stage of the disease of UC but it can Fig. 18.21 Yersinia pseudotuberculosis infection. Ileal biopsy
also be responsible for relapse of symptoms or cause pou- showing a characteristic granuloma with central necrosis. The
270
chitis. Histology is the best method for identification of lesion must be differentiated from tuberculosis and Crohn’s
this infection. Relapse of symptoms can also be the result disease. (H&E × 10)
IBD4E-18(255-276) 03/04/2003 10:36 AM Page 271
DIFFERENTIAL DIAGNOSIS
are usually multiple and large and can be confluent. a distorted crypt architecture and basal plasmacytosis.
Positive Ziehl staining suggests intestinal tuberculosis. Colonic mucosa both proximal and distal is usually
Central necrosis of a lymph follicle is suggestive of normal. The inflammatory features can mimic UC or
Yersinia infection. Salmonella, Shigella and Campylobacter CD. The relation of the inflammatory reaction with
infections can mimic UC. genuine IBD is unclear. Overall, it seems that diverticular
A medication history is indispensable in the investiga- disease-associated chronic colitis will precede the onset
tion of patients with diarrhea. A variety of drugs given of conventional ulcerative proctitis and colitis or genuine
either topically or systematically can cause colitis, ileo- CD in only a minority of cases.63
colitis or proctitis. Some of these may mimic UC. Non-
steroidal anti-inflammatory drug (NSAID)-induced Diversion colitis
lesions present a significant clinical problem. Usually the
Diversion colitis is an inflammatory process that occurs
patients are elderly. NSAIDs can induce small bowel and
in the bypassed colonic segment after surgical diver-
colonic lesions. Colitis induced by NSAIDs can present
sion of the fecal stream. In a defunctioned, previously
as non-specific colitis, de novo colitis, reactivation of
normal rectum, mild inflammation is already apparent
quiescent inflammatory bowel disease, allergic colitis
at 3 months. When continuity is restored, the changes
(with eosinophils), constipation with perforation (ster-
disappear. Histologic abnormalities show a spectrum of
coral ulcer), non-specific ulceration and fistulas related
changes ranging from mild colitis to those seen in severe
to diverticulosis. The microscopic distinction between SECTION 3
active ulcerative colitis. Lesions include aphthous ulcers,
active UC and drug-induced colitis is usually not so
crypt distortion, atrophy and abscesses, a villous colonic
difficult because NSAID-induced lesions lack major
surface, mucin granulomas and a mixed inflammatory
inflammation although architectural alterations of the
infiltrate with patchy lymphoid hyperplasia.The latter is
mucosa are common. The distinction with inactive UC
a particular feature of this condition. All these findings
is therefore more difficult (Fig. 18.22). In NSAID-
may mimic IBD. When the original process leading to
induced pathology, apoptosis of epithelial cells may be
diversion of the fecal stream is not an inflammatory
common in the crypts (as in graft-versus-host disease).62
bowel disease the histological diagnosis of diversion
Other drugs that can cause colitis or proctitis are penicil-
colitis is easy. However, when there is underlying UC,
lamine, gold salts, isotretinoin and methyldopa. Oral con-
the differential diagnosis is difficult. Features favoring
traceptives and cocaine tend to mimic ischemic colitis.
diversion colitis are variation in severity of the lesions
seen on multiple biopsies taken from one single area and
Diverticular disease-associated colitis the absence of morphologic changes in the proximal
A clinical syndrome of chronic colitis, localized to the (not bypassed) segment.
sigmoid colon and occurring in association with diver- It has been shown that the defunctioned rectum
ticular disease, has been recognized repeatedly. Mucosal from patients suffering from unequivocal ulcerative
biopsies of this condition show features of IBD including colitis who have undergone proximal colonic resection
may show transmural inflammation, fissures and epithe-
lioid granulomas.3 While these features would suggest a
diagnosis of CD, the temptation to change the underly-
ing diagnosis must be resisted, because the changes may
represent further manifestations of diversion colitis.
Only follow-up of the patient and the eventual appear-
ance of lesions in the small intestine may force a change
of diagnosis. In general, it seems that the condition
worsens in UC, while diversion is favorable in CD.
Lymphoid hyperplasia
Lymphoid hyperplasia is observed in chronic ulcerative
colitis per se, in a separate entity, described as lymphoid
follicular proctitis and in diversion colitis.
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
layer underneath the intercryptal surface epithelium and morphologically different from IBD. Yet, in some
and, circumferentially, around the upper part of the cases, collagenous or lymphocytic colitis can precede (or
crypts and by increased mucosal inflammation. For a follow) genuine UC or CD.
proper diagnosis, it is necessary to obtain several (at least
three) colonic biopsies, because the thickness of the Endometriosis
subepithelial collagen table varies throughout the colon.
To reduce false positivity a minimal value of 10 µm Ileal endometriosis may present with acute, chronic or
has been proposed. Plasma cells and lymphocytes are recurrent distal small bowel obstruction, in the same
increased in the lamina propria and eosinophils may be way as Crohn’s ileitis.The differential diagnosis with CD
focally numerous. Neutrophils are occasionally seen may be very difficult and is mostly not possible pre-
and crypt abscesses are rare. Surface epithelial cells are operatively. Intestinal endometriosis may mimic CD, but
flattened or cuboidal and sometimes desquamated and can also be associated with CD. Endometriotic deposits
goblet cells are reduced in number and size.Yet overall, in the bowel can induce microscopic mucosal lesions
the colonic mucosa has a preserved or only minimally resembling inflammatory bowel disease.
distorted crypt architecture. It should not be confused
with rare forms of amyloid colitis, where the sub- Miscellaneous
epithelial thickening is due to deposition of amyloid
(Fig. 18.23). Microscopic lesions similar to CD have been reported
The microscopic picture of lymphocytic colitis is in ileal and colonic biopsies from patients with reactive
characterized by diffuse lesions with an increase of arthritis and ankylosing spondylitis. Only a minority
inflammatory cells in the epithelium and lamina propria. of these patients developed genuine CD. Less common
The infiltrate is mixed in composition with eosinophils, diseases, such as the colitis of Behçet’s disease and
neutrophils (cryptitis and crypt abscesses), lymphocytes, other vasculitides can mimic CD. Endoscopic biopsies
plasma cells and mast cells.The number of intraepithelial are often inconclusive, except when small vessels
lymphocytes is significantly increased (24.6 ± 3 for 100 are involved. In chronic granulomatous disease and
epithelial cells; normal value 4.6 ± 1.5), whereas a non- Hermansky–Pudlak syndrome, a colitis complete with
significant increase of interepithelial lymphocytes is granulomas, which is indistinguishable from CD, can
noted in UC and CD. Epithelial mucin depletion is occur. The diagnostic feature is the presence of charac-
common in lymphocytic colitis. teristic histiocytes in both mucosa and submucosa.
Microscopic colitis may be associated with primary Occasionally, malignancies may simulate CD on radio-
ileal villous atrophy (PIVA), without alterations in the logical examinations. The most common examples of
upper small intestine. Microscopic colitis is clinically these are in the colon: the poorly differentiated signet-
ring cell carcinoma and metastases in the wall, and
in the small intestine: a neuroendocrine cancer of
the terminal ileum. Mucosal biopsies may show mild
inflammatory features and architectural alterations. The
finding of such features must be interpreted cautiously
and, as always, histology has to be combined with the
clinical history and other data in order to reach a
definite diagnosis and to solve the differential diagnostic
problem.
ment membrane), neoplastic transformation of the epi- Table 18.5 Biopsy classification of dysplasia
thelium excluding all reactive changes’.64 This definition (intraepithelial neoplasia) in inflammatory
stresses the nature and origin of the lesion, but its bowel disease
identification relies upon the recognition of morpho-
logical features resulting from cytological and architec- Negative
tural changes in routinely processed and hematoxylin Indefinite
and eosin-stained sections. Accumulated experience Positive
from several prospective studies shows that 6–10 differ- Low-grade dysplasia
High-grade dysplasia
ent biopsies from different sites might be sufficient to
detect significant dysplasia. Generally, the histological
features of dysplasia in IBD are comparable with those
seen in colonic adenomas in non-colitic patients and monly used classification, proposed by the International
include cytological criteria, such as variations in nuclear Study Group, two grades are distinguished.The category
position, size and chromatin pattern combined with ‘low-grade dysplasia’ includes cases of mild and
architectural distortion (Fig. 18.24). Although the mor- moderate dysplasia. The category ‘high-grade dysplasia’
phological spectrum forms a continuum, dysplasia is includes some cases of moderate dysplasia (particularly
divided into different categories according to the sever- those with prominent architectural alteration) and all
ity of the alterations, because of different implications cases of severe dysplasia and carcinoma in situ. The SECTION 3
for patient management (Table 18.5). In the most com- grade of dysplasia is always determined by the features
of the most dysplastic portion. The distinction between
high- and low-grade dysplasia is dependent primarily
on the degree of cytologic alterations. This classifica-
tion appears to be reproducible, although in general, it
appears that interobserver agreement is better for high-
grade dysplasia.
Surveillance studies have shown that a distinction has
to be made between IBD-related dysplasia, especially the
polypoid or raised type also known as dysplasia associ-
ated lesion or mass (DALM) and sporadic adenoma
occurring in IBD. While the latter is unequivocally a
neoplastic and hence a dysplastic lesion, its development
is unrelated to the underlying IBD. Furthermore, recent
evidence suggests that the molecular pathogenesis of
IBD-associated dysplasia is different in terms of order
and timing of genetic events. DALM in IBD should in
fact be defined as a poorly circumscribed protruding
lesion surrounded by dysplastic flat mucosa. It should
also be distinguished from ALM (adenoma-like mass),
when there is no surrounding dysplasia.65 The differential
diagnosis between polypoid IBD-associated dysplasia and
inflammatory pseudopolyps or dysplasia in inflammatory
pseudopolyps is another problem. Dysplasia in inflamma-
tory polyps is rare. The major problem is that these
polyps frequently contain areas of residual regenera-
tion and it may be difficult to make a clear distinction
between unequivocally neoplastic changes and regenera-
tion.The differential diagnosis between reparative lesions
and ‘genuine’ dysplasia in general may be difficult.
Whereas high-grade dysplasia can usually reliably be dis-
tinguished, the distinction between repair and low-grade
dysplasia may present a serious problem. Reparative
Fig. 18.24 Ulcerative colitis. Low-grade dysplasia, on the right
panel of the figure is characterized by the presence of tall cells of the surface may be distinguished from ‘genuine’
columnar cells with increased staining of the cytoplasm and dysplastic cells because of their shape (cuboidal or low
273
elongated nucleus. (H&E × 10) columnar versus crowded and high columnar) and
IBD4E-18(255-276) 03/04/2003 10:36 AM Page 274
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
REFERENCES
1 Schumacher G, Kollberg B, Sandstedt B. A prospective study of first
attacks of inflammatory bowel disease and infectious colitis.
Histologic course during the 1st year after presentation. Scand J
Gastroenterol 1994; 29:318–332.
2 Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy
diagnosis of suspected chronic idiopathic inflammatory bowel
disease. The British Society of Gastroenterology Initiative. J Clin Pathol
1997; 50:93–105.
3 Shepherd NA. Pathological mimics of chronic inflammatory bowel
disease. J Clin Pathol 1991; 44:726–733.
4 Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg
Fig. 18.25 Ulcerative colitis. Dysplasia in ulcerative colitis. Pathol 1989; 13:966–984.
Positive nuclear staining for p53 is clearly present in some
5 Segal GH, Petras RE. Small intestine. In: Sternberg SS ed. Histology for
samples and absent in others (immunohistochemistry × 4).
pathologists. New York: Raven: 1992:547–572.
6 Chang EB. Intestinal epithelial function and response to mucosal
injury. In: Kirsner JB ed. Inflammatory bowel diseases. Philadelphia:
WB Saunders; 2000:3–19.
because mucus secretion in dysplastic cells is often
7 Bejarano PA, Aranda-Michel J, Fenoglio-Preiser C. Histochemical and
abnormal. In addition, the presence of inflammation
immunohistochemical characterization of foamy histiocytes
orients also to reactive changes. Some of the more (muciphages and xanthelasma) of the rectum. Am J Surg Pathol 2000;
recently developed treatment modalities may indeed 24:1009–1015.
decrease the inflammatory reaction before completion of 8 Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis.
reparative phenomena. This discrepancy can result in Gastroenterology 1998; 115:182–250.
follow-up biopsies showing little or no inflammatory 9 Both H, Torp-Pedersen S, Kreiner S, et al. Clinical appearance at
activity and marked regeneration. The latter represents diagnosis of ulcerative colitis and Crohn’s disease in a regional patient
group. Scand J Gastroenterol 1983; 18:987–991.
pseudodysplasia and should not be mistaken for dyspla-
10 D’Haens G, Geboes K, Peeters M, et al. Patchy cecal inflammation
sia. Because of the diagnostic problems related to dyspla- associated with distal ulcerative colitis: a prospective endoscopic
sia other markers have been examined and tested to study. Am J Gastroenterol 1997; 92:1275–1279.
improve the reliability of the diagnosis. Changes in 11 Valdez R, Appelman H, Bronner MP, et al. Diffuse duodenitis associated
nuclear DNA content, reflecting gross chromosomal with ulcerative colitis. Am J Surg Pathol 2000; 24:1407–1413.
alterations can be identified with flow cytometry. 12 Bernstein CN, Shanahan F, Anton PA, et al. Patchiness of mucosal
Inactivation of tumour suppressor genes, such as p53 can inflammation in treated ulcerative colitis: a prospective study.
Gastrointest Endosc 1995; 42:232–237.
be identified using immunohistochemistry for the
13 Goldman H. Colonic biopsy in inflammatory bowel disease. Surg
demonstration of mutant p53 protein expression. Both Pathol 1991; 4:3–24.
the detection of aneuploidy and overexpression of p53
14 Seldenrijk CA, Morson BC, Meuwissen SGM, et al. Histopathological
can be useful for a correct diagnosis (Fig. 18.25). evaluation of colonic mucosal biopsy specimens in chronic
Colorectal cancer in UC is predominantly located in inflammatory bowel disease: diagnostic implications. Gut 1991;
the sigmoid and rectum. The prognosis is similar to the 32:1514–1520.
one found in the general population. The tumour stage 15 Rubio CA, Johansson C, Kock Y. A quantitative method of estimating
inflammation in the rectal mucosa.III. Chronic ulcerative colitis. Scan J
is essential for the prognosis.
Gastroenterol 1982; 17:1083–1087.
Carcinoma is also a well-recognized complication of
16 Dundas SAC, Dutton J, Skipworth P. Reliability of rectal biopsy in
CD, where it can develop in the small intestine and in distinguishing between chronic inflammatory bowel disease and
the colon in areas where there is or has been inflamma- acute self–limiting colitis. Histopathol 1997; 31:60–66.
tory disease.The carcinomas are often multiple.They are 17 Lee FD, Maguire C, Obeidat W, et al. Importance of cryptolytic lesions
usually adenocarcinomas and are often associated with and pericryptal granulomas in inflammatory bowel disease. J Clin
the presence of dysplasia in the colon and in the small Pathol 1997; 50:148–152.
intestine, suggesting that the development of malig- 18 Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates
acute self-limited colitis from ulcerative colitis. Gastroenterology 1987;
nancy in CD is similar to that of UC.66 The histological 92:318–328.
features of dysplasia are identical to those seen in UC 19 Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in
and the same classification can be used. Patients with colorectal biopsies and changes with time. Am J Surg Pathol 1998;
274
CD may also be at an increased risk for the develop- 22:983–989.
IBD4E-18(255-276) 03/04/2003 10:36 AM Page 275
REFERENCES
20 Powell-Tuck J, Day DW, Buckell NA, et al. Correlation between defined 42 Cook MG, Dixon MF. An analysis of the reliability of detection and
sigmoidoscopic appearances and other measurements of disease diagnostic value of various pathological features in Crohn’s disease
activity in ulcerative colitis. Dig Dis Sci 1982; 27:533–537. and ulcerative colitis. Gut 1973; 14:255–262.
21 Florèn CH, Benoni C, Willén R. Histologic and colonoscopic 43 Tanaka M, Saito H, Fukuda S, et al. Simple mucosal biopsy criteria
assessment of disease extension in ulcerative colitis. Scand J differentiating among Crohn’s disease, ulcerative colitis and other
Gastroenterol 1987; 22:459–462. forms of colitis: measurement of validity. Scand J Gastroenterol 2000;
22 Geboes K, Riddell R, Öst Ä, et al. A reproducible grading scale for 35:281–286.
histological assessment of inflammation in ulcerative colitis. Gut 2000; 44 Geboes K, Ectors N, D’Haens G, et al. Is ileoscopy with biopsy
47:404–409. worthwhile in patients presenting with symptoms of IBD. Am J
23 Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative Gastroenterol 1998; 93:201–206.
colitis: what does it mean? Gut 1991; 32:174–178. 45 Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor
24 Keren DF, Appelman HD, Dobbins WO III, et al. Correlation of secreting cell lineage by mucosal ulceration in human gastrointestinal
histopathologic evidence of disease activity with the presence of stem cells. Nature 1990; 343:82–85.
immunoglobulin-containing cells in the colons of patients with 46 Schmitz-Moormann P, Schäg M. Histology of the lower intestinal tract
inflammatory bowel disease. Hum Pathol 1984; 15:757–763. in Crohn’s disease of children and adolescents. Path Res Pract 1990;
25 Odze R, Antonioli D, Peppercorn M, et al. Effect of topical 186: 479–484.
5-amino-salicylic acid (5-ASA) therapy on rectal mucosal biopsy 47 Gomes P, Du Boulay C, Smith CL, et al. Relationship between disease
morphology in chronic ulcerative colitis. Am J Surg Pathol 1993; activity and colonoscopic findings in patients with colonic
17:869–875. inflammatory bowel disease. Gut 1986; 27:92–95.
26 Geboes K. Pathology of inflammatory bowel diseases (IBD): variability 48 Beatie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as
with time and treatment. Colorectal Dis 2001; 3:2–12. the primary therapy in children with small bowel Crohn’s disease. SECTION 3
27 Sanders DSA. The differential diagnosis of Crohn’s disease and Aliment Pharmacol Ther 1994; 8:609–615.
ulcerative colitis. Baillière’s Clin Gastroenterol 1998; 12:19–33. 49 Baert F, D’Haens GR, Peeters M, et al. Tumor necrosis factor α antibody
28 Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent (infliximab) therapy profoundly downregulates the inflammation in
Crohn’s disease at the ileocolonic anastomosis after curative surgery. Crohn’s ileocolitis. Gastroenterology 1999; 116:22–8.
Gut 1984; 25:665–672. 50 Korelitz BJ, Sommers SC. Response to drug therapy in Crohn’s disease.
29 Oberhuber G, Stangl P C, Vogelsang H, et al. Significant association of Evaluation by rectal biopsy and mucosal cell counts. Clin
strictures and internal fistula formation in Crohn’s disease. Virchows Gastroenterol 1984; 6:123–127.
Arch 2000; 437:293–297. 51 Geboes K, Collins S. Structural abnormalities of the nervous system in
30 Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear anti-neutrophil Crohn’s disease and ulcerative colitis. Neurogastroenterol Mot 1998;
cytoplasmic antibodies in patients with Crohn’s disease define a 10:189–202.
clinical subgroup. Gastroenterology 1996; 110:1810–1819. 52 Dvorak AM, Osage JE, Monahan RA, et al. Crohn’s disease: transmission
31 Sheehan AL, Warren BF, Gear MWL, et al. Fat-wrapping in Crohn’s electron microscopic studies. III. Target tissues proliferation of and
disease: pathological basis and relevance to surgical practice Br J Surg injury to smooth muscle and the autonomic nervous system. Hum
1992; 79:955–959. Pathol 1980; 11:620–634.
53 Belai A, Boulos PB, Robson T, et al. Neurochemical coding in the small
32 Cook MG. The size and histological appearances of mesenteric lymph
intestine of patients with Crohn’s disease. Gut 1997; 40:767–774.
nodes in Crohn’s disease. Gut 1972; 13:970–972.
54 Wakefield AJ, Sankey EA, Dhillon AP, et al. Granulomatous vasculitis in
33 Chambers TJ, Morson BC. The granuloma in Crohn’s disease. Gut 1979;
Crohn’s disease. Gastroenterology 1991; 100:1279–1287.
20:269–274.
55 Mottet NK. Intestinal histopathology of regional enteritis:
34 Heresbach D, Heresbach-Le Berre N, Ramée MP, et al. Fréquence et
histopathologic spectrum of regional enteritis and ulcerative colitis.
valeur pronostique du granulome épithélioïde au cours des maladies
Philadelphia: WB Saunders; 1971.
inflammatoires chroniques de l’intestin. Gastroenterol Clin Biol 1999;
23:1376–1387. 56 Tanaka M, Riddell RH. The pathological diagnosis and differential
diagnosis of Crohn’s disease. Hepatogastroenterol 1990; 37:18–31.
35 Rotterdam H, Korelitz B I, Sommers SC. Microgranulomas in grossly
normal rectal mucosa in Crohn’s disease. Am J Clin Pathol 1977; 57 Graham MF, Diegelmann RF, Elson CO, et al. Collagen content and
67:550–554. types in the intestinal strictures of Crohn’s disease. Gastroenterology
1988; 94:257–265.
36 Dvorak A, Connell AB, Dickersin GR. Crohn’s disease: a scanning
electron microscopic study. Hum Pathol 1979; 10:165–177. 58 Gelbmann CM, Mestermann S, Gross V, et al. Strictures in Crohn’s
disease are characterized by an accumulation of mast cells colocalised
37 Fujimura Y, Hosobe M, Kihara T. Ultrastructural study of M cells from
with laminin but not with fibronectin or vitronectin. Gut 1999;
colonic lymphoid nodules obtained by colonoscopic biopsy. Dig Dis
45:210–217.
Sci 1992; 37:1089–1098.
59 D’Haens G, Rutgeerts P, Geboes K, et al. The natural history of
38 Tanaka M, Riddell RH. The pathological diagnosis and differential
esophageal Crohn’s disease: three patterns of evolution. Gastrointest
diagnosis of Crohn’s disease. Hepatogastroenterol 1990; 37:18–31.
Endosc 1994; 40:296–300.
39 Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in 60 Oberhuber G, Puspok A, Oesterreicher C, et al. Focally enhanced
Crohn’s disease. Gut 1993; 34:375–381. gastritis: a frequent type of gastritis in patients with Crohn’s disease.
40 Lennard-Jones JE. Crohn’s disease: Definition, pathogenesis and Gastroenterology 1997; 112:698–706.
aetiology. In: Wright R, ed. Recent advances in gastrointestinal 61 Ectors NL, Dixon MF, Geboes KJ, et al. Granulomatous gastritis: a
pathology. London: WB Saunders; 1980: 173–189. morphological and diagnostic approach. Histopathol 1993; 23:55–61.
41 Surawicz CM, Belic L. Rectal biopsy helps to distinguish acute 62 Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal
self–limited colitis from idiopathic inflammatory bowel disease. anti-inflammatory drugs. Report of four cases and review of the 275
Gastroenterology 1984; 86:104–113. literature. Arch Intern Med 1992; 152:625–632.
IBD4E-18(255-276) 03/04/2003 10:36 AM Page 276
SECTION 3. DIAGNOSIS: A CLINICIAN’S PERSPECTIVE CHAPTER 18. HISTOPATHOLOGY OF CROHN’S DISEASE AND ULCERATIVE COLITIS
63 Makapugay LM, Dean PJ. Diverticular-disease-associated chronic 65 Odze RD, Brown CA, Hartmann CJ, et al. Genetic alterations in chronic
colitis. Am J Surg Pathol 1996; 20:94–102. ulcerative colitis associated adenoma-like DALMS are similar to non-
64 Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory colitic sporadic adenomas. Am J Surg Pathol 2000; 24:1209–1216.
bowel disease: standardized classification with provisional clinical 66 Sigel JE, Petras RE, Lashner BA, et al. Intestinal adenocarcinoma in
applications. Hum Pathol 1983; 14:931–968. Crohn’s disease. A report of 30 cases with a focus on coexisting
dysplasia. Am J Surg Pathol 2000; 23:651–655.
276